Home > Company Introduction
Company Overview
GSH BIO-TECH is an innovative high-tech enterprise with the core of enzyme catalysis technology in the field of synthetic biology and the interdisciplinary application of multidisciplinary technology. The aim is to develop biotechnology and industrialization of high value-added API. The p ioneer of the global enzymatic catalyzed coupled ATP regeneration technology, we advocate green production and has been committed to providing customers with better and more environmentally friendly products and services. As a powerful production-oriented enterprise, we truly integrate R&D, production and sales, with stable supply and quality for customers and double guarantee of service.The company’s main products are L-glutathione reduced(GSH), β-Nicotinamide Mononucleotide(NMN), Citicoline Sodium(CDPC) and other raw materials. The acid market share ranks among the top three in China, and the products are exported to Europe, America, South Korea, India and other parts of the world.
-
ManufacturerBusiness Type
-
2017Year Established
-
Above 100,000 square metersFactory Size
-
US$2.5 Million - US$5 MillionAnnual Export Value
Company Detail
Transparency is the foundation of our partnership. Below is a comprehensive overview of our operational metrics, from business scale to global market reach, giving you a clear picture of our capabilities.
-
301 - 500 People Total Employees
-
11-20 People Sales Staff
-
20-50 People Quality Inspectors
-
HACCP, TL900, QS9000, SA8000, ISO9001, ISO9004, ISO17799, ISO9000, ISO14000, ISO10441, ISO16949, TS16969, ISO19011:2000, OHSAS18001, Others Product Certifications
-
US$2.5 Million - US$5 Million Annual Export Value
-
North America, South America, Eastern Europe, Southeast Asia, Africa, Oceania, Mid East, Eastern Asia, Western Europe, Central America, Northern Europe, Southern Europe, South Asia, Domestic Market Main Markets
-
shanghai Port of Shipment
-
Pharmaceutical Intermediate Main Industry
-
Our ServicesGSH BIO-TECH is an innovative high-tech enterprise with the core of enzyme catalysis technology in the field of synthetic biology and the interdisciplinary application of multidisciplinary technology. The aim is to develop biotechnology and industrialization of high value-added API.